- 2010: year of niacin?2010 | First Faculty of Medicine
- Niacin-laropiprant combination: novel approach not only to treatment of dyslipidemia2011 | Faculty of Pharmacy in Hradec Králové
- Niacin / laropiprant (Tredaptive) - new in the treatment of dyslipidemia2011 | First Faculty of Medicine
- Combination of niacin and laropiprant: another possibility of influencing not only dyslipidemia2011 | First Faculty of Medicine
- Fixed combination niacin/laropiprant - revival of the use of a class of lipid-modifying drugs2010 | Faculty of Medicine in Pilsen
- Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia2010 | First Faculty of Medicine
- Fall 2010: rosuvastatin, niacin and the new internal medicine2010 | First Faculty of Medicine
- Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?2015 | First Faculty of Medicine
- Analysis of Nicotinic Acid and Its Metabolites by HPLC-MS/MS2015 | First Faculty of Medicine
- Pleiotropic effects of niacin: Current possibilities for its clinical use2016 | First Faculty of Medicine
- The Use of a Hydrogel Matrix for Controlled Delivery of Niacin to the Gastrointestinal Tract for Treatment of Hyperlipidemia2015 | First Faculty of Medicine
- Letter by Vitek et al Regarding Article, "Niacin Inhibits Vascular Inflammation via the Induction of Heme Oxygenase-1"2012 | First Faculty of Medicine
- Nicotinic acid plus laropiprant2011 | First Faculty of Medicine, Third Faculty of Medicine
- Pharmacotherapy of HLP and DLP2010 | First Faculty of Medicine
- Dyslipidaemia in patients with type 2 diabetes2011 | First Faculty of Medicine
- Influence of HDL cholesterol2011 | First Faculty of Medicine
- Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidlines related to the diagnostics and treatment of dyslipidemias issued in 2011 +32013 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Dyslipidemia in 20122012 | First Faculty of Medicine
- Heart Protection Study 2 - Treatment of HDL to reduce the incidence of vascular events (HPS2-Thrive);2013 | First Faculty of Medicine
- Nicotinic acid: An unjustly neglected remedy2006 | First Faculty of Medicine
- Do we need new lipid lowering drugs?2007 | First Faculty of Medicine
- Combination therapy of dyslipoproteinemia2006 | First Faculty of Medicine
- Modern trends of lipid-lowering therapy +1Publication without faculty affiliation
- Lipid lowering treatment in ACS2003 | Faculty of Physical Education and Sport
- Hyperlipoproteinemias2003 | Faculty of Physical Education and Sport
- Treatment of hyperlipidemia - modern trends2003 | Faculty of Physical Education and Sport